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Selenium deficiency has been suggested by several studies
to be associated with cancer risk. We conducted a case-
control study in Szczecin, a region of northwestern
Poland, on 86 cases of lung cancer, 87 cases of laryngeal
cancer and an equal number of healthy controls. We stu-
died the serum level of selenium and genotypes for four
variants in four selenoprotein genes (GPX1, GPX4,
TXNRD2 and SEP15) and the odds of being diagnosed
with lung or laryngeal cancer.
Among lung cancer cases, the mean selenium level was
63.2 µg/l, compared to a mean level of 74.7 µg/l for their
matched controls (p < 0.0001). Among laryngeal cancer
cases, the mean selenium level was 64.8 µg/l, compared to
a mean level of 76.3 µg/l for their matched controls (p <
0.0001). Compared to a serum selenium value in the low-
est of four categories (≤ 60 µg/l) a selenium level in the
highest category (> 80 µg/l) was associated with an odds
ratio of 0.10 (95% CI 0.03 to 0.34; p = 0.0002) for lung
cancer and 0.24 (95% CI 0.10 to 0.59; p = 0.002) for laryn-
geal cancer. In four selenoproteins studied here we found
a modest associations of genetic variants in GPX1 and
GPX4 with lung and TXNRD2 with laryngeal cancer risk.
In this region of endemic low selenium level, there is a
strong inverse association between the level of serum
selenium and the risks of lung and laryngeal cancer.
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